Chemical and bio-chemical products, preparations and substances; chemical reagents other than for medical or veterinary purposes; chemical reagents for laboratory use; chemical test reagents; diagnostic reagents for in vitro use; diagnostic reagents and buffers; reagents in kit form; chemical preparations and substances for use in scientific analysis and research; preparations and substances for biological and genetic research; receptors, nuclear receptors; agonists and anti-agonists; chemogenetic preparations and substances; ion channel inhibitors; proteins; peptides and amino acids; in-vivo photo pharmacology preparations and substances (term considered linguistically incorrect by the International Bureau - Rule 13 (2) (b) of the Regulations); dyes, labels and stains for chemical, bio-chemical or molecular analysis (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); enzymes and enzymatic preparations and substances for scientific purposes; stem cells other than for medical or veterinary purposes

Reagents for medical or veterinary purposes; reagents in kit form; test and testing reagents; in-vivo diagnostic reagents; laboratory reagents for medical or veterinary use; reagents for laboratory testing (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); chemical diagnostic reagents; chemical products or preparations for analysis (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); biological products or preparations for analysis (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); antibodies; chemical products or preparations for use in radio chemical analysis (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); chemical, biological or biochemical products or preparations for use in scientific analysis (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); biochemical preparations or substances for medical, diagnostic or pharmaceutical use; proteins (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); peptides and amino acids (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); in-vitro photo pharmacology preparations and substances (term considered linguistically incorrect by the International Bureau - Rule 13 (2) (b) of the Regulations); antibiotics; reagents and buffers; medical dyes, labels and stains (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); enzymes and enzymatic preparations and substances for medical purposes; stem cells for medical or veterinary purposes; genome (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); DNA (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); antivirals for pharmaceutical or medical purposes

Scientific, research, optical, weighing, measuring, photographic, testing apparatus and instruments; imaging apparatus not for medical purposes; DNA chips; software; medical and scientific software; computer software applications; downloadable computer software applications; downloadable electronic publications; downloadable scientific materials; downloadable educational or teaching material

Education and training services; electronic publications (not downloadable) (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); online publications (not downloadable) (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); organisation of conferences, seminars or exhibitions; provision of guides and calculators for scientific education or training (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); provision of scientific, chemical, biological, biochemical or life science papers and publications for education or training and advisory and consultancy services in connection with all of the aforesaid services (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)

Advisory and consultancy services relating to scientific research and development; chemical, pharmacology, biological and biochemical research and development services; laboratory research and development services; pharmaceutical research and development services; chemical, biological and biochemical analysis services; molecular biology and genetic research services; chemical, scientific, biological and biochemical advisory and consultancy services; the provision of tools and guides for use in scientific, biological and biochemical research and development and advisory and consultancy services in connection with all of the aforesaid services (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)